Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: the randomised CirCe01 trial

Background CirCe01 trial aimed to assess the clinical utility of circulating tumour cell (CTC)-based monitoring in metastatic breast cancer (MBC) patients beyond the third line of chemotherapy (LC). Methods CirCe01 was a prospective, multicentre, randomised trial (NCT01349842) that included patients...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of cancer 2021-03, Vol.124 (7), p.1207-1213
Hauptverfasser:	Cabel, Luc, Berger, Frédérique, Cottu, Paul, Loirat, Delphine, Rampanou, Aurore, Brain, Etienne, Cyrille, Stacy, Bourgeois, Hugues, Kiavue, Nicolas, Deluche, Elise, Ladoire, Sylvain, Campone, Mario, Pierga, Jean-Yves, Bidard, Francois-Clement
Format:	Artikel
Sprache:	eng
Schlagworte:	692/4028/67/1347 692/53/2422 Aged Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biomedical and Life Sciences Biomedicine Breast cancer Breast Neoplasms - blood Breast Neoplasms - drug therapy Breast Neoplasms - pathology Cancer Research Carcinoma, Lobular - blood Carcinoma, Lobular - drug therapy Carcinoma, Lobular - secondary Chemotherapy Drug Resistance Epidemiology Female Follow-Up Studies Humans Metastases Metastasis Middle Aged Molecular Medicine Neoplasm Invasiveness Neoplastic Cells, Circulating - pathology Oncology Prognosis Prospective Studies Survival Rate Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!